The current SLS market cap is 32.22M. The company's latest EPS is USD -1.2882 and P/E is -0.78.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -7.15M | -9.45M | -11.28M | -9.05M | -9.36M |
Net Income | -7.02M | -9.12M | -11.1M | -8.84M | -9.27M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 1.9M | 7.6M | 1M |
Operating Income | -31.09M | -20.04M | -16.98M | -19.59M | -41.95M |
Net Income | -41.25M | -27.95M | -16.76M | -20.7M | -41.3M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 26M | 20.94M | 29.1M | 18.57M | 8.09M |
Total Liabilities | 13.4M | 16.09M | 15.94M | 13.72M | 11.91M |
Total Equity | 12.6M | 4.85M | 13.17M | 4.84M | -3.83M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 16.92M | 16.61M | 46.05M | 26.28M | 20.94M |
Total Liabilities | 11.67M | 10.52M | 18.09M | 5.93M | 16.09M |
Total Equity | 5.25M | 6.09M | 27.96M | 20.35M | 4.85M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -18.66M | -23.81M | -12.13M | -19.69M | -26.59M |
Investing | -4.5M | -4.5M | N/A | -2.5M | -5.5M |
Financing | 23.15M | 24.08M | 18.9M | 18.88M | 18.93M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -30.42M | -17.64M | -10.42M | -26.02M | -23.81M |
Investing | N/A | N/A | N/A | N/A | -4.5M |
Financing | 23.12M | 19.57M | 38.44M | 12.07M | 24.08M |
Market Cap | 32.22M |
Price to Earnings Ratio | -0.78 |
Price to Sales Ratio | 32.05 |
Price to Cash Ratio | 1.87 |
Price to Book Ratio | 6.61 |
Dividend Yield | - |
Shares Outstanding | 32.06M |
Average Volume (1 week) | 2.24M |
Average Volume (1 Month) | 1.79M |
52 Week Change | -16.25% |
52 Week High | 1.914 |
52 Week Low | 0.4986 |
Spread (Intraday) | 0.01 (0.99%) |
Company Name | SELLAS Life Sciences Group Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.sellaslifesciences.com/home/default.aspx |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.